Total words: 3825 | 2-word phrases: 1018 | 3-word phrases: 1129 | 4-word phrases: 1154
PAGE INFO
Title | Try to keep the title under 60 characters (48 characters) TRI - Making RBQM Simple for all Clinical Trials |
Description | Try to keep the meta description between 50 - 160 characters (139 characters) TRI's platform simplifies RBQM for all clinical trials. Less complexity, more clarity. Less spreadsheets, more innovation. Think OPRA. |
Keywords | Meta keywords are not recommended anymore (0 characters)
|
H1 | No H1 tag on the page (0 characters)
|
ONE WORD PHRASES 524 Words
# |
Keyword |
H1 |
Title |
Des |
Volume |
Position |
Suggest |
Frequency |
Density |
1 | and | | | | | | | 45 | 8.59% |
2 | the | | | | | | | 45 | 8.59% |
3 | to | | | | | | | 39 | 7.44% |
4 | rbqm | | | | | | | 27 | 5.15% |
5 | of | | | | | | | 26 | 4.96% |
6 | for | | | | | | | 22 | 4.20% |
7 | with | | | | | | | 21 | 4.01% |
8 | a | | | | | | | 21 | 4.01% |
9 | you | | | | | | | 21 | 4.01% |
10 | clinical | | | | | | | 21 | 4.01% |
TWO WORD PHRASES 1018 Words
# |
Keyword |
H1 |
Title |
Des |
Volume |
Position |
Suggest |
Frequency |
Density |
1 | clinical trial | | | | | | | 11 | 1.08% |
2 | risk assessment | | | | | | | 8 | 0.79% |
3 | clinical trials | | | | | | | 7 | 0.69% |
4 | you can | | | | | | | 6 | 0.59% |
5 | to our | | | | | | | 6 | 0.59% |
6 | what is | | | | | | | 6 | 0.59% |
7 | clinical research | | | | | | | 6 | 0.59% |
8 | clinical research? | | | | | | | 6 | 0.59% |
9 | risk management | | | | | | | 5 | 0.49% |
10 | and patient | | | | | | | 5 | 0.49% |
11 | is the | | | | | | | 5 | 0.49% |
12 | for you | | | | | | | 5 | 0.49% |
13 | you as | | | | | | | 4 | 0.39% |
14 | team to | | | | | | | 4 | 0.39% |
15 | course you | | | | | | | 4 | 0.39% |
16 | can our | | | | | | | 4 | 0.39% |
17 | our pricing | | | | | | | 4 | 0.39% |
18 | friendly team | | | | | | | 4 | 0.39% |
19 | a solution | | | | | | | 4 | 0.39% |
20 | solution that | | | | | | | 4 | 0.39% |
THREE WORD PHRASES 1129 Words
# |
Keyword |
H1 |
Title |
Des |
Volume |
Position |
Suggest |
Frequency |
Density |
1 | of course you | | | | | | | 4 | 0.35% |
2 | your company chat | | | | | | | 4 | 0.35% |
3 | course you can | | | | | | | 4 | 0.35% |
4 | works for you | | | | | | | 4 | 0.35% |
5 | that works for | | | | | | | 4 | 0.35% |
6 | solution that works | | | | | | | 4 | 0.35% |
7 | a solution that | | | | | | | 4 | 0.35% |
8 | find a solution | | | | | | | 4 | 0.35% |
9 | to find a | | | | | | | 4 | 0.35% |
10 | team to find | | | | | | | 4 | 0.35% |
11 | friendly team to | | | | | | | 4 | 0.35% |
12 | chat to our | | | | | | | 4 | 0.35% |
13 | company chat to | | | | | | | 4 | 0.35% |
14 | with your company | | | | | | | 4 | 0.35% |
15 | as you grow | | | | | | | 4 | 0.35% |
16 | scales with your | | | | | | | 4 | 0.35% |
17 | pricing scales with | | | | | | | 4 | 0.35% |
18 | our pricing scales | | | | | | | 4 | 0.35% |
19 | can our pricing | | | | | | | 4 | 0.35% |
20 | you can our | | | | | | | 4 | 0.35% |
21 | what is the | | | | | | | 4 | 0.35% |
22 | is the difference | | | | | | | 4 | 0.35% |
23 | the difference between | | | | | | | 4 | 0.35% |
24 | difference between rbm | | | | | | | 4 | 0.35% |
25 | between rbm and | | | | | | | 4 | 0.35% |
26 | rbm and rbqm? | | | | | | | 4 | 0.35% |
27 | you as you | | | | | | | 4 | 0.35% |
28 | for you as | | | | | | | 4 | 0.35% |
29 | in clinical research? | | | | | | | 3 | 0.27% |
30 | and patient safety | | | | | | | 3 | 0.27% |
FOUR WORD PHRASES 1154 Words
# |
Keyword |
H1 |
Title |
Des |
Volume |
Position |
Suggest |
Frequency |
Density |
1 | find a solution that | | | | | | | 4 | 0.35% |
2 | works for you as | | | | | | | 4 | 0.35% |
3 | difference between rbm and | | | | | | | 4 | 0.35% |
4 | between rbm and rbqm? | | | | | | | 4 | 0.35% |
5 | of course you can | | | | | | | 4 | 0.35% |
6 | course you can our | | | | | | | 4 | 0.35% |
7 | you can our pricing | | | | | | | 4 | 0.35% |
8 | can our pricing scales | | | | | | | 4 | 0.35% |
9 | our pricing scales with | | | | | | | 4 | 0.35% |
10 | you as you grow | | | | | | | 4 | 0.35% |
11 | for you as you | | | | | | | 4 | 0.35% |
12 | that works for you | | | | | | | 4 | 0.35% |
13 | what is the difference | | | | | | | 4 | 0.35% |
14 | solution that works for | | | | | | | 4 | 0.35% |
15 | a solution that works | | | | | | | 4 | 0.35% |
16 | to find a solution | | | | | | | 4 | 0.35% |
17 | team to find a | | | | | | | 4 | 0.35% |
18 | friendly team to find | | | | | | | 4 | 0.35% |
19 | company chat to our | | | | | | | 4 | 0.35% |
20 | your company chat to | | | | | | | 4 | 0.35% |
21 | with your company chat | | | | | | | 4 | 0.35% |
22 | scales with your company | | | | | | | 4 | 0.35% |
23 | pricing scales with your | | | | | | | 4 | 0.35% |
24 | is the difference between | | | | | | | 4 | 0.35% |
25 | the difference between rbm | | | | | | | 4 | 0.35% |
26 | with a free 30minute | | | | | | | 2 | 0.17% |
27 | the fda’s radical new | | | | | | | 2 | 0.17% |
28 | 30 days if you | | | | | | | 2 | 0.17% |
29 | inside the fda’s radical | | | | | | | 2 | 0.17% |
30 | for 30 days if | | | | | | | 2 | 0.17% |
31 | free for 30 days | | | | | | | 2 | 0.17% |
32 | for free for 30 | | | | | | | 2 | 0.17% |
33 | us for free for | | | | | | | 2 | 0.17% |
34 | activity management and reporting | | | | | | | 2 | 0.17% |
35 | collaboration activity management and | | | | | | | 2 | 0.17% |
36 | try us for free | | | | | | | 2 | 0.17% |
37 | if you want well | | | | | | | 2 | 0.17% |
38 | can try us for | | | | | | | 2 | 0.17% |
39 | efficiency and patient safety | | | | | | | 2 | 0.17% |
40 | you can try us | | | | | | | 2 | 0.17% |
EXTERNAL LINKS